Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial.
about
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionThe efficacy of a Hansenula-derived 20 kDa pegylated interferon alpha-2a in the treatment of genotype 4 chronic hepatitis C.Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.
P2860
Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@en
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@nl
type
label
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@en
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@nl
prefLabel
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@en
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Nitazoxanide plus pegylated in ...... a randomized controlled trial.
@en
P2093
Dalia M Deraz
Hany M Shehab
Tamer M Elbaz
P2860
P304
P356
10.1111/LIV.12267
P577
2013-07-24T00:00:00Z